| Literature DB >> 35532025 |
Elham Qanbari Alaee1, Omid Saed2, Sahel Khakpoor3, Reza Ahmadi4, Mahsa Ali Mohammadi5, Majid Yoosefi Afrashteh6, Zekrolah Morovati6.
Abstract
In response to the high rate of comorbidity among different types of emotional disorders in children, Transdiagnostic Unified Protocol of Emotional disorder in children (UP-C) was developed to address common underlying mechanisms in the development and maintenance of emotional disorders using empirically supported cognitive and behavioural strategies. Although, studies supported the effectiveness of this protocol in the treatment of wide range of emotional disorders, further studies are needed to examine its effect on transdiagnostic factors. The present study aimed to investigate the efficacy of the UP-C on negative affect, anxiety sensitivity and perceived control in children with emotional disorders. During this randomized controlled trial, 34 children aged 7 to 13 with emotional disorders were randomly assigned to treatment (n=18) and control (n=16) groups. The treatment group and their parents received 15 sessions of UP-C. Negative Affect Schedule for Children (PANASNA- C), Children's Anxiety Sensitivity Index (CASI), Anxiety Control Questionnaire-Children (ACQ-C) were carried out in all phases (pre-treatment, post-treatment, 3 and 8 months follow- up). The results showed that following UP-C, negative affect (hedges'g=2.01) and anxiety sensitivity (hedges'g=1.05) were significantly reduced, and perceived control (hedges'g= -2.36) was significantly improved. The results remained relatively constant during the follow-ups. Findings provide evidence that the UP-C has significant effect on negative affect, anxiety sensitivity and perceived control as roots of emotional disorders.Entities:
Year: 2022 PMID: 35532025 PMCID: PMC9153761 DOI: 10.4081/ripppo.2022.588
Source DB: PubMed Journal: Res Psychother ISSN: 2239-8031
CLUES skills, session by session overview of the UP-C.
| Modals/Sessions | Goals of the child group | Activities | Goals of the parent group |
|---|---|---|---|
| Consider How I feel Session 1-4 Group | • Introduce to the UP-C and increase motivation | • Identify rewards for new behaviours | • Introduce to the EPBs and their OPBs |
| Look at my thoughts Session 5 Group | • Focus on the cognitive components | • Play with the concept of ‘flexible thinker’ | • Discuss the EPB of |
| Use detective thinking and problem solving | o Alter cognitive appraisal | • Practice flexible thinking and antecedent reappraisal | • Introduce to EPB of ‘overcontrol/overprotection’ and its OPB, ‘healthy independence-granting’ |
| Experience my emotions | • Teach ‘present-moment awareness’ and ‘non-judgmental awareness’ | • Exposure to a scary toy | • Introduce to the EPB of ‘excessive modelling of intense emotions’ and its OPB, ‘healthy emotional modelling’ |
| Stay healthy and happy | • Review the skills | • Celebration of progress made in the treatment | • Review OPBs |
UP-C, Unified Protocol for Children; BDA, Before, During, and After; EPB, Emotional Parenting Behaviours; OPB, Opposite Parenting Behaviours. In general, parents learn and practice all the skills of the group of children that are not repeated in the table.
Figure 1.CONSORT diagram illustrating participant flow during the study.
Demographic and clinical patient characteristics.
| UP-C (n=18) | C (n=16) | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| Age | 10.22 | 1.96 | 10.13 | 2.09 | t(32)= 0.14, P=0.656 |
|
|
|
|
| ||
| Gender | |||||
| Male | 4 | 22.20 | 7 | 43.70 | 2 |
| Female | 14 | 77.80 | 9 | 56.30 | |
|
|
|
|
|
| |
| SAD | 5 (27.75) | 3 (10.72) | 1 (6.25) | 5 (18.25) | |
| GAD | 8 (44.50) | 3 (10.72) | 8(50) | 0 (0) | |
| PD | 0 (0) | 4 (14.28) | 1 (6.25) | 3 (11.11) | |
| SoD | 1 (5.55) | 5 (17.85) | 0 (0) | 8 (29.64) | |
| OCD | 1 (5.55) | 2 (7.14) | 4(25) | 2 (7.40) | |
| MDD | 3 (16.65) | 11 (39.29) | 2 (12.50) | 9 (33.33) | |
C, Control group; SAD, Separation Anxiety Disorder; GAD, Generalized Anxiety Disorder; PD, Panic Disorder; SoD, Social Anxiety Disorder; OCD, Obsessive Compulsive Disorder; MDD, Major Depressive Disorder.
Outcome measures at each assessment.
| UP-C | Control | t (df) | F (df) | F (df) | F (df) | |||
|---|---|---|---|---|---|---|---|---|
| M | SD | M | SD | Pre-treatment comparison | Within-group comparison | Between-group comparison | time e × a group | |
|
| ||||||||
| Pre-treatment | 16.06 | 3.21 | 15.00 | 2.68 | t(32)=1.03, P=309 | |||
| Post-treatment | 9.44 | 3.38 | 15.75 | 2.29 | F(3,96)=21.83, P<0.001 | F(1,32)=28.44, P<0.001 | F(3,96)=48.99, P<0.001 | |
| Follow-up 1 | 10.00 | 2.40 | 16.62 | 2.91 | ||||
| Follow-up 2 | 10.94 | 3.01 | 17.75 | 3.02 | ||||
|
| ||||||||
|
| ||||||||
| Pre-treatment | 18.17 | 4.00 | 17.06 | 3.15 | t(32)=0.88, P=382 | |||
| Post-treatment | 14.89 | 3.69 | 18.44 | 4.27 | F(2.66,85.15)=3.23, P<0.031 | F(1,32)=5.62, P<0.024 | F(2.66,85.15)=15.71, P<0.001 | |
| Follow-up 1 | 15.06 | 3.17 | 19.19 | 4.99 | ||||
| Follow-up 2 | 15.72 | 3.00 | 2.37 | 4.13 | ||||
|
| ||||||||
| Pre-treatment | 8.28 | 2.11 | 7.31 | 1.62 | t(32)=1.48, P=148 | |||
| Post-treatment | 6.44 | 1.54 | 7.69 | 1.62 | F(2.59,82.95)=3.33, P<0.029- | F(1,32)=3.28, P<0.080 | F(2.59,82.95)=12.12, P<0.001 | |
| Follow-up 1 | 6.33 | 1.24 | 7.94 | 2.21 | ||||
| Follow-up 2 | 6.56 | 1.58 | 8.31 | 1.96 | ||||
|
| ||||||||
| Pre-treatment | 6.78 | 1.44 | 6.12 | 1.59 | t(32)=1.26, P=217 | |||
| Post-treatment | 5.83 | 1.20 | 6.81 | 1.47 | F(2.65,85.94)=1.18, P<0.321 | F(1,32)=1.98, P<0.179 | F(2.68,85.94)=6.27, P<0.002 | |
| Follow-up 1 | 6.06 | 0.87 | 7.12 | 1.67 | ||||
| Follow-up 2 | 6.33 | 1.49 | 7.12 | 1.50 | ||||
|
| ||||||||
| Pre-treatment | 33.22 | 6.25 | 30.50 | 4.23 | t(32)=1.47, P=152 | |||
| Post-treatment | 27.17 | 5.28 | 32.94 | 5.12 | F(2.47,79.17)=3.33, P<0.023 .33, | F(1,32)=7.25, P<0.11 | F(2.47,79.17)=19.02, P<0.001 | |
| Follow-up 1 | 27.44 | 4.39 | 34.25 | 6.67 | ||||
| Follow-up 2 | 28.61 | 5.09 | 35.81 | 5.31 | ||||
|
| ||||||||
|
| ||||||||
| Pre-treatment | 9.00 | 6.03 | 10.25 | 5.67 | t(32)= -0.62, P=540 | |||
| Post-treatment | 20.05 | 3.38 | 9.44 | 5.90 | F(2.65,84.90)=20.66, P<0.001 | F(1,32)=16.19, P<0.001 | F(2.65,84.90)=29.51, P<0.001 | |
| Follow-up 1 | 17.78 | 4.53 | 8.68 | 5.85 | ||||
| Follow-up 2 | 18.72 | 6.20 | 9.56 | 6.52 | ||||
|
| ||||||||
| Pre-treatment | 4.50 | 2.50 | 5.19 | 3.01 | t(32)= -0.73, P=473 | |||
| Post-treatment | 8.94 | 1.55 | 4.31 | 2.24 | F(2.02,64.54)=13.68, P<0.001 | F(1,32)=20.12, P<0.001 | F(2.02,64.54)=32.17, P<0.001 | |
| Follow-up 1 | 8.61 | 1.46 | 4.44 | 2.45 | ||||
| Follow-up 2 | 8.06 | 2.48 | 3.94 | 2.20 | ||||
|
| ||||||||
| Pre-treatment | 13.50 | 7.98 | 15.43 | 8.21 | t(32)= -0.70, P=491 | |||
| Post-treatment | 29.00 | 4.78 | 13.75 | 7.70 | F(2.31,73.88)=21.77, P<0.001 | F(1,32)=19.12 P<0.001, | F(2.02,64.54)=37.18, P<0.001 | |
| Follow-up 1 | 26.39 | 5.45 | 13.12 | 8.01 | ||||
| Follow-up 2 | 26.78 | 8.36 | 13.50 | 8.17 | ||||
PANAS (NA), Positive and Negative Affect Schedule (Negative Affect); CASI, Childhood Anxiety Sensitivity Index; ACQ, Anxiety Control Questionnaire.
Figure 2.Comparison of outcomes in pre-treatment, post-treatment, 3-month follow-up, and 8-month follow-up for NA, AS, and PC.
Effect sizes.
| Group | Pre-Post | Pre-F1 | Pre-F2 | Post-F1 | Post-F2 | F1-F2 | |
|---|---|---|---|---|---|---|---|
| PANAS (NA) | UP-C | 2.01 | 2.13 | 1.64 | –0.19 | –0.47 | 0.03 |
| C | –0.30 | –0.58 | –0.96 | –0.33 | –0.75 | –0.38 | |
|
| |||||||
| Physical | UP-C | 0.85 | 0.86 | 0.69 | –0.05 | –0.25 | –0.21 |
| C | –0.37 | –0.51 | –0.90 | –0.16 | –0.42 | –0.23 | |
| Mental | UP-C | 1.00 | 1.01 | 0.92 | 0.08 | –0.08 | –0.16 |
| C | –0.23 | –0.23 | –0.56 | –0.13 | –0.34 | –0.19 | |
| Social | UP-C | 0.72 | 0.61 | 0.31 | –0.22 | –0.37 | –0.22 |
| C | –0.45 | –0.62 | –0.65 | –0.20 | –0.21 | 0.00 | |
| Total | UP-C | 1.05 | 1.07 | 0.81 | –0.06 | –0.28 | –0.25 |
| C | –0.52 | –0.67 | –1.11 | –0.22 | –0.55 | –0.26 | |
|
| |||||||
| Internal | UP-C | –2.18 | –1.60 | –1.56 | 0.57 | 0.27 | –0.17 |
| C | 0.14 | 0.27 | 0.11 | 0.13 | –0.02 | –0.15 | |
| External | UP-C | –2.13 | –2.01 | –1.43 | 0.22 | 0.43 | 0.27 |
| C | 0.33 | 0.27 | 0.47 | –0.06 | 0.17 | 0.21 | |
| Total | UP-C | –2.36 | –1.89 | –1.63 | 0.51 | 0.33 | –0.06 |
| C | 0.21 | 0.29 | 0.24 | 0.08 | 0.03 | –0.05 |
C, Control group; PANAS (NA), Positive and Negative Affect Schedule (Negative Affect); CASI, Childhood Anxiety Sensitivity Index; ACQ, Anxiety Control Questionnaire.